Related Experiment Video
Updated: Aug 13, 2026

Genetic Studies of Human DNA Repair Proteins Using Yeast as a Model System
Published on: March 18, 2010
Saccharomyces cerevisiae lacking Snm1, Rev3 or Rad51 have a normal S-phase but arrest permanently in G2 after
K F Grossmann1, A M Ward, R E Moses
1Department of Molecular and Medical Genetics, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Mail Code: L103, Portland, OR 97201, USA.
Abstract:
The role of Snm1, Rev3 and Rad51 in S-phase after cisplatin (CDDP) DNA treatment has been examined. When isogenic deletion mutants snm1 delta, rev3 delta and rad51 delta were arrested in G1 and treated with doses of CDDP causing significant lethality (<20% survival in the mutant strains), they progressed through S-phase with normal kinetics. The mutants arrested in G2 like wild-type cells, however they did not exit the arrest and reenter the cell cycle. This finding demonstrates that these genes are not required to allow DNA replication in the presence of damage. Therefore, Snm1, Rev3 and Rad51 may act after S to allow repair. At high levels of damage (<40% survival in wild-type cells) S-phase was slowed in a MEC1-dependent fashion. The cross-link incision kinetics of snm1 delta and rev3 delta mutants were also examined; both showed no deficiencies in incision of cross-linked DNA.
Insights
This study investigated the roles of Snm1, Rev3, and Rad51 in DNA replication after cisplatin treatment. These genes are not essential for S-phase progression in damaged cells but appear crucial for cell cycle re-entry post-replication.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Cisplatin (CDDP) is a chemotherapy agent that induces DNA cross-links, posing a challenge for DNA replication.
- Understanding the cellular mechanisms that allow DNA replication and repair following CDDP treatment is crucial for cancer therapy.
Purpose of the Study:
- To investigate the roles of Snm1, Rev3, and Rad51 in facilitating DNA replication during S-phase after cisplatin-induced DNA damage.
- To determine if these proteins are required for cell cycle progression and exit from G2 arrest following DNA damage.
Main Methods:
- Utilized isogenic deletion mutants (snm1Δ, rev3Δ, rad51Δ) and wild-type yeast strains.
- Cells were arrested in G1 and treated with varying doses of cisplatin (CDDP).
- Monitored cell cycle progression (S-phase kinetics, G2 arrest) and survival rates.
- Assessed cross-link incision kinetics in specific mutants.
Main Results:
- Snm1, Rev3, and Rad51 are not required for normal S-phase progression in the presence of cisplatin-induced DNA damage.
- Mutant cells arrested in G2 like wild-type cells but failed to exit the arrest and re-enter the cell cycle.
- High levels of DNA damage slowed S-phase in a MEC1-dependent manner.
- snm1Δ and rev3Δ mutants showed no deficiency in the incision of cross-linked DNA.
Conclusions:
- Snm1, Rev3, and Rad51 likely function in post-S-phase DNA repair rather than facilitating replication through damaged DNA.
- These genes are essential for cell cycle re-entry after DNA replication and subsequent repair processes.
- The findings contribute to understanding DNA damage tolerance mechanisms in response to chemotherapy agents.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
DNA Damage Can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...

